Helius Medical Technologies Announces Newly Constituted Scientific Advisory Board

Biotech Investing

Helius Medical Technologies announced the formation of a scientific advisory board.

Helius Medical Technologies (TSX:HSM; OTCQB:HSDT) announced the formation of a scientific advisory board.
As quoted in the press release:

“I am delighted we have recruited a good friend and respected colleague to take on this important responsibility,” said outgoing chair, Dr. Jonathan Sackier. “Dr. Chopra’s work as a neurosurgeon and entrepreneur position him ideally to assume the mantle of Chairman of our Scientific Advisory Board (SAB). Gopal and I, together with the company leadership, have reconfigured our SAB to guide Helius towards commercialization of our investigational and disruptive PoNS™ Therapy. We want to thank Dr. Ron Alterman, Dr. Jennifer Sweet, Dr. Jim Surmeier, Dr. Reggie Edgerton, Major General Gale Pollock (ret) and Dr. Rick Celebrini for their service. I can now focus as Chief Medical Officer on the other exciting projects we are working on as we move towards bringing PoNS™ Therapy to the numerous patients who may benefit. Our excellent team is growing and Gopal enhances our reach into the medical community.”

Click here to read the full press release.

Source: globenewswire.com

The Conversation (0)
×